insights_auto
Why is NXTCL down 5,62%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0,23
arrow_downward
-5,62%(-0,013) 1D
16 Nov., 17:12:13 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0,26
High
SEK 0,26
Low
SEK 0,22
Mkt. cap
28,63 m
Avg. vol.
1,00 m
Volume
396,66 k
52-wk high
SEK 1,78
52-wk low
SEK 0,20
EPS
-SEK 0,45
Shares outstanding
111,39 m
No. of employees
21
Open
SEK 0,26
High
SEK 0,26
Low
SEK 0,22
Mkt. cap
28,63 m
Avg. vol.
1,00 m
Volume
396,66 k
52-wk high
SEK 1,78
52-wk low
SEK 0,20
EPS
-SEK 0,45
Shares outstanding
111,39 m
No. of employees
21
News stories
From web sources and news partners
Yahoo Finance
·
10 minute gelede
What's dragging down the S&P 500? Apple in focus
Investing.com
·
22 minute gelede
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 uur gelede
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
ChartMill
·
1 uur gelede
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded19 Mrt. 2014
Headquarters-
SectorHealth Care
Industry-
Websitenextcellpharma.com